Deletion of c-FLIP from CD11bhi Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis is a progressive lung disease with complex pathophysiology and fatal prognosis. Macrophages (MΦ) contribute to the development of lung fibrosis; however, the underlying mechanisms and specific MΦ subsets involved remain unclear. During lung injury, two subsets of lung MΦ coexist: Siglec-Fhi resident alveolar MΦ and a mixed population of CD11bhi MΦ that primarily mature from immigrating monocytes. Using a novel inducible transgenic system driven by a fragment of the human CD68 promoter, we targeted deletion of the antiapoptotic protein cellular FADD-like IL-1β–converting enzyme–inhibitory protein (c-FLIP) to CD11bhi MΦ. Upon loss of c-FLIP, CD11bhi MΦ became susceptible to cell death. Using this system, we were able to show that eliminating CD11bhi MΦ present 7–14 days after bleomycin injury was sufficient to protect mice from fibrosis. RNA-seq analysis of lung MΦ present during this time showed that CD11bhi MΦ, but not Siglec-Fhi MΦ, expressed high levels of profibrotic chemokines and growth factors. Human MΦ from patients with idiopathic pulmonary fibrosis expressed many of the same profibrotic chemokines identified in murine CD11bhi MΦ. Elimination of monocyte-derived MΦ may help in the treatment of fibrosis. We identify c-FLIP and the associated extrinsic cell death program as a potential pathway through which these profibrotic MΦ may be pharmacologically targeted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
the Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972
Self-citationOrigin and functions of tissue macrophages
Epelman, S., Lavine, K. J., & Randolph, G. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.013 · Cited by 1,585
Guilliams, M., De Kleer, I., Henri, S., Post, S., Vanhoutte, L., De Prijck, S., Deswarte, K., Malissen, B., Hammad, H., & Lambrecht, B. N. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131199 · Cited by 1,276
Tsou, C.-L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., & Charo, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29919 · Cited by 1,152
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. S., & Perlman, H. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0086ma · Cited by 838
Cited by
Items 101–200 of 209
Atif, S. M., Gibbings, S. L., & Jakubzick, C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7837-3_6 · Cited by 23
Self-citationZhang, N., Yang, K., Bai, J., Yi, J., Gao, C.-C., Zhao, J., Liang, S.-Q., Wei, T., Feng, L., Song, L., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201903086rr · Cited by 23
Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms
Doskaliuk, B., Zaiats, L., Yatsyshyn, R., Gerych, P., Cherniuk, N., & Zimba, O. (2020) · Rheumatology International · doi:10.1007/s00296-020-04658-6 · Cited by 21
“In fact, a mixed M1/M2 population is associated with SSc-ILD in human [75] and murine models [76, 77].”
BackgroundXu, H. N., Lin, Z., Gandhi, C. K., Amatya, S., Wang, Y., Li, L. Z., & Floros, J. (2020) · Antioxidants · doi:10.3390/antiox9100915 · Cited by 21
“In contrast, SP-A is shown to induce reactive oxygen species and cytokine responses by local AM in response to infection [77].”
BackgroundMorrell, E. D., Holton, S. E., Lawrance, M., Orlov, M., Franklin, Z., Mitchem, M. A., DeBerg, H., Gersuk, V. H., Garay, A., Barnes, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43223-0 · Cited by 20
Immune-epithelial cell interactions in lung development, homeostasis and disease
Yoshida, M., Arzili, R., & Nikolić, M. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106703 · Cited by 19
“…selective genetic deletion of monocyte-derived alveolar macrophages improved fibrosis outcomes, further suggesting their pro-fibrotic role 65,66 . o o Single cell RNA-seq analysis of human fibrotic lung tissue revealed the presence of monocyte-derived alveolar macrophages with pro-fibrotic…”
Cadherin-11 Regulates Macrophage Development and Function
To, S., Chavula, T., Pedroza, M., Smith, J., & Agarwal, S. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.795337 · Cited by 18
Tylek, T., Wong, J., Vaughan, A. E., & Spiller, K. L. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122545 · Cited by 17
The Lung in Rheumatoid Arthritis—Friend or Enemy?
Anton, M.-L., Cardoneanu, A., Burlui, A., Mihai, I. R., Richter, P., Bratoiu, I., Macovei, L. A., & Rezuş, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126460 · Cited by 17
“In a preclinical study, alveolar cell injury can activate inflammation and macrophages derived from monocytes, leading to fibrosis [133].”
BackgroundNoninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1
Mannes, P. Z., Adams, T. S., Farsijani, S., Barnes, C. E., Latoche, J. D., Day, K. E., Nedrow, J. R., Ahangari, F., Kaminski, N., Lee, J. S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adm9817 · Cited by 17
Németh, J., Schundner, A., & Frick, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.611728 · Cited by 17
“Murine models of bleomycin-induced fibrosis suggested that (monocyte-derived) macrophages could contribute to progression of fibrosis through overreactive responses to alveolar injury (42, 43).”
BackgroundMulticompartmental analysis of the murine pulmonary immune response by spectral flow cytometry
Chang, M. Y., Brune, J. E., Black, M. C., Altemeier, W. A., & Frevert, C. W. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00317.2022 · Cited by 16
Aschner, Y., Nelson, M., Brenner, M., Roybal, H. M., Beke, K. M., Meador, C., Foster, D. G., Correll, K. A., Reynolds, P. R., Anderson, K. C., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00235.2019 · Cited by 15
Self-citationCass, S. P., Mekhael, O., Thayaparan, D., McGrath, J. J. C., Revill, S. D., Fantauzzi, M. F., Wang, P., Reihani, A., Hayat, A. I., Stevenson, C. S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.740330 · Cited by 15
“Moreover, in preclinical pulmonary fibrosis models, aberrant tissue remodelling has been specifically associated with increased Mo-AM (9, 10, 19) and reduced IM1 (8).”
BackgroundOkabe, Y., Toda, E., Urushiyama, H., Terashima, Y., Kunugi, S., Kajimoto, Y., Terasaki, M., Matsushima, K., Saito, A., Yamauchi, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71770-z · Cited by 14
Wan, X., Xiao, Y., Tian, X., Lu, Y., & Chu, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109570 · Cited by 14
Macrophage expressed tartrate‐resistant acid phosphatase 5 promotes pulmonary fibrosis progression
Bergwik, J., Bhongir, R. K. V., Padra, M., Adler, A., Olm, F., Lång, P., Lindstedt, S., Andersson, G., Egesten, A., & Tanner, L. (2024) · Immunology · doi:10.1111/imm.13748 · Cited by 14
“In murine bleo-mycin models, which resemble the pathology of IPF, chemokine receptor type 2 ( Ccr2 ) deletion mitigates fibrosis, with similar effects seen following deletion of CD11b-expressing monocyte-derived alveolar macrophages [7].”
BackgroundInfluentialIRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge
Reader, B. F., Sethuraman, S., Hay, B. R., Becket, R. V. T., Karpurapu, M., Chung, S., Lee, Y. G., Christman, J. W., & Ballinger, M. N. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900466 · Cited by 14
CXCL11 reprograms M2-biased macrophage polarization to alleviate pulmonary fibrosis in mice
Kim, J. Y., Cho, D.-W., Choi, J.-Y., Jeong, S., Kang, M., Kim, W., Hong, I., Song, H., Chang, H., Yang, S., et al. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01320-7 · Cited by 13
“Studies by Alexander et al . and McCubbrey et al . suggest that monocyte-derived macrophages, but not tissue-resident macrophages, are primarily responsible for the progression of fibrosis [24, 25].”
Development and validation of a mouse model of contemporary cannabis smoke exposure
Fantauzzi, M. F., Cass, S. P., McGrath, J. J. C., Thayaparan, D., Wang, P., Stämpfli, M. R., & Hirota, J. A. (2021) · ERJ Open Research · doi:10.1183/23120541.00107-2021 · Cited by 13
Macklin, M., Thompson, C., Kawano-Dourado, L. B., Ventura, I. B., Weschenfelder, C., Trostchansky, A., Marcadenti, A., & Tighe, R. M. (2023) · Cells · doi:10.3390/cells12182206 · Cited by 13
Monocyte and macrophage function in respiratory viral infections
Arish, M., & Sun, J. (2023) · Animal Diseases · doi:10.1186/s44149-023-00095-7 · Cited by 13
“Conversely, recruited macrophages are also directly responsible for lung fibrosis (McCubbrey et al. 2018; Wendisch et al. 2021), a common repercussion of post-severe viral pneumonia, including coronavirus disease 2019 (COVID-19) (Wendisch et al. 2021).”
BackgroundPan, T. S., Feng, Y., Li, Y., Yang, Y., Zhou, J., & Song, Y. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-680 · Cited by 12
Liang, X., Li, Y., Wu, Y., Wu, T., Huang, D., Tang, Z., Cheng, L., Tan, C., Liao, R., Zhao, J., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04266-w · Cited by 12
“…that intratracheal administration of liposomal clodronate to deplete resident macrophages has no effect on PF, whereas elimination of monocyte-derived macrophages expressing CD11b may help alleviate fibrosis [45], suggesting that the primary source of macrophages responsible for PF is monocytes.”
Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease
Morozan, A., Joy, S., Fujii, U., Fraser, R. S., Watters, K. A., Martin, J. G., & Colmegna, I. (2023) · Scientific Reports · doi:10.1038/s41598-023-47083-y · Cited by 11
“Following 42 days of HOCl injections, an increase in the number of Mo-AM was expected given the pathobiologic role of Mo-Ams in fibrosis 38 .”
BackgroundWang, S., Zhou, H., Mao, J., Zhang, Y., Qi, Y., Mei, P., Jin, X., Zhang, J., Luo, L., & You, J. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123420 · Cited by 11
Xu, C., Sun, P., Jiang, Q., Meng, Y., Dong, L., Wang, X., Hu, X., Li, C., Li, G., Zheng, R., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02444-6 · Cited by 10
“These immune activities are essential for maintaining homeostasis, immune surveillance, cellular debris removal, microbial clearance, and in fl ammation resolution [8].”
Kim, S., Nouws, J., Ruwisch, J., Woodard, G. A., Cooley, J. C., Khoury, J., Sun, H., Doherty, E. H., Piecychna, M., Manning, E. P., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adr2277 · Cited by 11
Self-citationActivation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis
Hreich, S. J. D., Juhel, T., Leroy, S., Ghinet, A., Brau, F., Hofman, V., Hofman, P. M., & Vouret‐Craviari, V. (2023) · eLife · doi:10.7554/elife.88138.4 · Cited by 10
Markov, N. S., Esposito, A. J., Senkow, K. J., Schleck, M. J., Cusick, L., Yu, Z., Sokolenko, Y. V., Diaz, E., Jonasson, E., Swaminathan, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.07.669006 · Cited by 10
“We and others have causally linked the recruitment of profibrotic monocyte-derived alveolar macrophages to lung fibrosis development and maintenance in animal models 5,6,8,10 .”
The Importance of Lung Innate Immunity During Health and Disease
Ryanto, G. R. T., Suraya, R., & Nagano, T. (2025) · Pathogens · doi:10.3390/pathogens14010091 · Cited by 9
Jankowski, K., Lemay, S.-E. S., Lozano‐Ojalvo, D., Pérez‐Rodríguez, L., Sauvaget, M., Breuils‐Bonnet, S., Formoso, K., Jagana, V., Ochoa, M. T., Zhang, S., et al. (2025) · European Respiratory Journal · doi:10.1183/13993003.02250-2024 · Cited by 9
“Our results indicate that Epac1 inhibition with AM-001 decreased neutrophil and monocyte-derived macrophage infiltration in the lungs, which is associated with a reduced pathology in BLM-induced PF [83].”
Myeloid Heterogeneity Mediates Acute Exacerbations of Pulmonary Fibrosis
Larson‐Casey, J. L., Saleem, K., Surolia, R., Pandey, J., Mack, M., Antony, V. B., Bodduluri, S., Bhatt, S. P., Duncan, S. R., & Carter, A. B. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300053 · Cited by 9
Grove, L. M., Snyder, C., Boulton, A. M., Mao, H., Abraham, S., Ricci, H., Orsini, E. M., Southern, B. D., Olman, M. A., & Scheraga, R. G. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111135 · Cited by 9
Advancing Lung Immunology Research: An Official American Thoracic Society Workshop Report
Rahimi, R. A., Cho, J. L., Jakubzick, C., Khader, S. A., Lambrecht, B. N., Lloyd, C. M., Molofsky, A. B., Talbot, S., Bonham, C. A., Drake, W. P., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0167st · Cited by 8
Self-citationPTPα promotes fibroproliferative responses after acute lung injury
Aschner, Y., Correll, K. A., Beke, K. M., Foster, D. G., Roybal, H. M., Nelson, M., Meador, C., Strand, M. J., Anderson, K. C., Moore, C. M., et al. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00436.2021 · Cited by 8
Isolation and Analysis of Macrophage Subsets from the Mouse and Human Lung
King, E. M., Hume, P. S., Janssen, W. J., & McCubbrey, A. L. (2022) · Methods in Molecular Biology · doi:10.1007/978-1-0716-2364-0_18 · Cited by 7
Self-citationLi, Z., Ma, J., Wang, X., Zhu, L., Gan, Y., & Dai, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1464762 · Cited by 7
The Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review
Liu, H., Cui, H., & Liu, G. (2025) · Fibrosis · doi:10.70322/fibrosis.2025.10004 · Cited by 7
“A different strategy to study the contribution of Mo-AMs in pulmonary fibrosis was used by McCubbrey et al. [49].”
Cho, I. S., Yaghmour, A., Joshi, A., Gupta, P., Sanborn, M. A., Zappia, M. P., Wong, S. W., Cheng, G., Frolov, M. V., Rehman, J., et al. (2025) · Advanced Materials · doi:10.1002/adma.202504590 · Cited by 7
c-FLIP as a master regulator of immune homeostasis and disease mechanisms
Urbini, E., Adamo, A., Hu, Y., Giacobazzi, L., Dusi, S., Sanctis, F. D., Carbone, C., Gibellini, D., Pilotto, S., Corbo, V., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08771-5 · Cited by 6
“This phenotype illustrates c-FLIP ’ s essential contribution to macrophage-mediated homeostasis [165, 168].”
MicroRNAs regulate alveolar macrophage homeostasis and its function in lung fibrosis
Parajuli, N., Yao, Y., Khalasawi, N., Yin, C., Zhang, Q., Adrianto, I., Hans, A., Zhou, L., & Mi, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1598306 · Cited by 5
Boulton, A. M., Grund, M. E., Wang, Y., Orsini, E. M., Liu, Y., Abraham, S., Grove, L. M., Musich, R. J., Snyder, C. M., Ricci, H., et al. (2025) · Science Signaling · doi:10.1126/scisignal.adt1539 · Cited by 5
Sun, Y., Xu, H., Lu, T., Li, T., Wang, Y., Fan, X., Jiang, Y., Cai, M., He, P., & Liu, J. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01182-9 · Cited by 5
Vieira-Santos, F., Brito, R. M. D. M., Lopes, C. D. A., Leal-Silva, T., Souza, J. L. N., Amorim, C. C. O., Ruas, A. C. L., Padrão, L. D. L. S., Kraemer, L. R., Oliveira, F. M. S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33739 · Cited by 5
“…AMs populations can vary during infection based on different levels of Siglec-F and MHC-II expression, although the role of Siglec-F in AMs is not clear [53,54], we suggest that the modulation of this marker is involved in the activation state alterations of AMs during PbNK65 infection [55,56].”
BackgroundZhang, W., Yuan, L.-L., Li, J.-R., Zheng, T., & Fan, L.-H. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112029 · Cited by 4
Macrophages and Pulmonary Fibrosis
Chen, S., Song, X., & Lv, C. (2025) · Current Molecular Medicine · doi:10.2174/0115665240286046240112112310 · Cited by 4
Shah, K. A., Ullah, S., Razzaq, A., Khan, M. N., Ali, T., Hussian, Y., Iqbal, H., & Cui, J.-H. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00441-w · Cited by 4
Guo, R., Zhou, Y., Lin, F., Li, M., Tan, C., & Xu, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.981604 · Cited by 4
“And if this line of macrophages was deleted, the fibrosis would be attenuated (Misharin et al., 2017; McCubbrey et al., 2018).”
BackgroundMekhael, O., Revill, S. D., Hayat, A. I., Cass, S. P., MacDonald, K., Vierhout, M., Ayoub, A., Reihani, A., Padwal, M., Imani, J., et al. (2023) · Immunology and Cell Biology · doi:10.1111/imcb.12637 · Cited by 4
“Further, an expansion of monocyte-derived macrophage populations was associated with enhanced fibrogenesis in mouse models of lung fibrosis.(4,8,9) Notably, macrophage function is influenced by the immune environment.”
BackgroundGe, R. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-4845 · Cited by 4
“However, Mo-AMs are also profibrotic and if excessive or persist can contribute to lung fibrosis (4,5).”
BackgroundRole of macrophages in the pathogenesis of pulmonary fibrosis
Maksimova, A. A., Shevela, Е. Y., & Chernykh, E. R. (2024) · Immunologiya · doi:10.33029/1816-2134-2024-45-2-235-244 · Cited by 3
Fakihi, S. E., Allam, A. E., Tahoune, H., Najimi, N., Kadi, C., Ibrahimi, A., Bourkadi, J. E., & Seghrouchni, F. (2023) · Human Antibodies · doi:10.3233/hab-230005 · Cited by 3
“…characterized by the recruitment, proliferation, and activation of a collection of cells, including neutrophils, macrophages, natural killer (NK) cells, T cells, B cells, fibroblasts, epithelial and endothelial cells, that together make up the cellular response that orchestrates tissue repair [13].”
Sun, J., & Zeng, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1534903 · Cited by 2
Kass-Gergi, S., Holcomb, N. P., Maiden, M. M., Eisenlohr, L. C., & Vaughan, A. E. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00189.2025 · Cited by 2
“These cells release key profibrotic factors, including TGF-β , matrix metalloproteinases (MMPs), and CCL18 that drive fibroblast recruitment and ECM remodeling (80, 97, 98).”
The Involvement of MicroRNAs in Innate Immunity and Cystic Fibrosis Lung Disease: A Narrative Review
Carbone, A., Sajid, N., Soccio, P., Tondo, P., Lacedonia, D., Gioia, S. D., & Conese, M. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48010058 · Cited by 2
Monocyte-mediated mechanisms in idiopathic pulmonary fibrosis: opportunities for early intervention
Zhiguo, M. A. O., Liu, Y., Han, C., Yang, X., Lin, X., Tian, S., & Miao, M. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02254-2 · Cited by 2
“CD11b hi macrophage-like monocytes (MMs) are significant contributors to the pro - duction of pro-fibrotic chemokines, notably through the upregulation of CCL2 and CCL24, during the progression of IPF [108 ].”
Research Progress of Interstitial Lung Disease Based on Single‐Cell Sequencing Technology
Li, S., zhou, T., 张继英, Zhang, L., Li, B., Li, B., Dai, J., Yu, R., Li, Y., & Li, S. (2026) · Canadian Respiratory Journal · doi:10.1155/carj/8863968 · Cited by 2
Modulation of Myeloid Cell Function Using Conditional and Inducible Transgenic Approaches
McCubbrey, A. L., & Janssen, W. J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8570-8_13 · Cited by 2
Self-citationWang, Y., Fan, W., Guo, Y., Sun, L., Hu, Y., Chen, J., Gong, L., & Xie, Z. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117768 · Cited by 2
Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
O’Dwyer, D. N., & Moore, B. B. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201904-0891ed · Cited by 2
Bordag, N., Biasin, V., Schnoegl, D., Valzano, F., Jandl, K., Nagy, B. M., Sharma, N., Wygrecka, M., Kwapiszewska, G., & Marsh, L. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.22.106690 · Cited by 2
Pathogen-specific host responses define distinct pneumonia endotypes in the human lungPreprint
Markov, N. S., Możejko, M., Guggilla, V., Łazȩcka, M., Donnelly, H. K., Donayre, A., Fenske, S. W., Peltekian, A., Puczko-Szymański, B., Szymczak, P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.12.724509 · Cited by 2
Slamf7 is dispensable in mouse models of acute lung injury
King, E. M., McClendon, J. D., Trinh, T., Matsuda, J. L., Lyn-Kew, K. H., McCubbrey, A. L., Mould, K. J., Henson, P. M., & Janssen, W. J. (2024) · ERJ Open Research · doi:10.1183/23120541.00345-2024 · Cited by 1
“Our group has previously shown that monocytes that are recruited to the lungs during acute inflammation mature into recruited airspace macrophages (RecAMs) that have proinflammatory and profibrotic transcriptional profiles [2, 3].”
BackgroundSelf-citationCooley, J. C., Penick, S. K., Wilson, J. A., Javkhlan, N., Foster, D. G., Edelman, B., Schott, C. A., Humphries, S. M., Lynch, D. A., Schwartz, D. A., et al. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag045 · Cited by 1
Self-citationAntifibrotic monocyte activation by nanoparticles resolves murine pulmonary fibrosis
Viola, H., Carter, H. M., Griffin, K., Costa, R. M., McDonald, R. G., Callow, B. W., Santos, F. G. D. L., Panovich, P. M., Carey, S., Martinez, M., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124388 · Cited by 1
“We identified major myeloid subsets in the lung using established markers (Tables S7 and S8) [76-78].”
Kase, K., Watanabe, S., Horie, M., Muto, A., Iwasaki, K., Akasaki, K., Kobayashi, T., Arai, S., Koba, H., Yamamura, K., et al. (2026) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00123.2026 · Cited by 1
Lung Macrophages: Pivotal Immune Effector Cells Orchestrating Acute and Chronic Lung Diseases
van Eeden, S. F., & Sin, D. D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102420 · Cited by 1
Role of macrophages in prevention and control of diseases and their upregulation through cowpathy
Chauhan, R. S., & Chauhan, D. (2022) · International Journal of Cow Science · doi:10.18231/j.ijcs.2022.004 · Cited by 1
Shiohama, Y., Nakamura, J., & Nakamura, M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c02051 · Cited by 1
Siglec-F Deficiency Prevents Fibrosis after Bleomycin-induced Acute Lung Injury
Orlov, M., Hara, N., Rangarajan, S., Jaramillo, A. M., Ye, Q., Romo-Perez, Y. M., Ngo, K., Needell, J. C., Harder, A. Q., Jia, F., et al. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0402le · Cited by 1
Self-citationInfluenza A Virus after Radiotherapy Amplifies Lung Injury and Monocyte-derived Macrophage Responses
Groves, A. M., Johnston, C. J., Paris, N. D., Salama, N., McGraw, M., Blanc, R., Hernady, E., Finkelstein, J. N., & Marples, B. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2025-0113oc · Cited by 1
AGO HITS-CLIP in Adipose Tissue Reveals miR-29 as a Post-Transcriptional Regulator of LeptinPreprint
O’Connor, S., Murphy, E. A., Szwed, S. K., Kanke, M., Marchildon, F., Darnell, R. B., Sethupathy, P., & Cohen, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.991422 · Cited by 1
Characterization of inflammatory response in PBMCs using single-cell RNA sequencing
de Cevins, C. (2022) · theses.fr (ABES) · doi:10.70675/fbb352f1z61fdz46f8za8acz13b48482932f · Cited by 1
McCubbrey, A. L., & Janssen, W. J. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202406-1164ed · Cited by 1
“Combined with prior clinical reports and substantial evidence from animal models showing that monocyte-derived macrophages are necessary for fi brosis development (9, 10), it is attractive to hypothesize that circulating monocytes promote disease pathogenesis.”
ResultSelf-citationMacrophage Phenotypes in Lung Fibrosis
Koss, C. K. (2021) · KOPS (University of Konstanz) · Cited by 1
Khaliullin, T. O. (2020) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7820
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosisPreprint
Hreich, S. J. D., Juhel, T., Leroy, S., Ghinet, A., Brau, F., Hofman, V., Hofman, P. M., & Vouret‐Craviari, V. (2023) · eLife · doi:10.7554/elife.88138.1
Author Response: Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis
Hreich, S. J. D., Juhel, T., Leroy, S., Ghinet, A., Brau, F., Hofman, V., Hofman, P. M., & Vouret‐Craviari, V. (2024) · eLife · doi:10.7554/elife.88138.4.sa3
Rôle de l'immunomodulateur P2RX7 dans le cancer et la fibrose pulmonaire
Hreich, S. J. D. (2022) · theses.fr (ABES) · doi:10.70675/4b399e7fzb436z4e8fz8045z90c0862c799d
Unraveling the regulatory cell death pathways in pulmonary fibrosisPreprint
Sun, J., & Zeng, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4781780/v1
Natural Killer (NK) and Innate Lymphoid Cell responses to autologous and allogeneic tumors
Thaller, A. (2023) · theses.fr (ABES) · doi:10.70675/2b1b5377z266fz484bzaaf8z6358f3c1c53c
NF-kB related disorders : from immunodeficiency to autoimmunity
Riller, Q. (2023) · theses.fr (ABES) · doi:10.70675/f3f15a82z0c32z4629za486zd0252dab180a
Inflammatory Cells of the Lung: Macrophages
Smith, L. C., Malaviya, R., Radbel, J. M., Laskin, J. D., & Laskin, D. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00238-2
Nathwani, V., Weeratunga, P. N., Woo, J., Denney, L., Vuppusetty, C., Hu, T., Zulfikar, S., Achaiah, A., Parker, H., Chuang, H.-W., et al. (2025) · medRxiv · doi:10.1101/2025.05.09.25326523
Yapping about macrophages in fibrotic lung disease
Lafyatis, R., & Valenzi, E. (2025) · European Respiratory Journal · doi:10.1183/13993003.00075-2025
Kwak, D., Bradley, P. B., Subbotina, N., Ling, S., Teitz‐Tennenbaum, S., Osterholzer, J. J., Sisson, T. H., & Kim, K. K. (2023) · Figshare · doi:10.6084/m9.figshare.24819609
Qin, W., Spek, C. A., Scicluna, B. P., van der Poll, T., & Duitman, J. (2022) · Figshare · doi:10.6084/m9.figshare.20110691
Choi, S. M., Mo, Y., Bang, J.-Y., Ko, Y. G., Ahn, Y. H., Kim, H. Y., Koh, J., Yim, J.-J., & Kang, H.-R. (2024) · Figshare · doi:10.6084/m9.figshare.26572882
Kwak, D., Bradley, P. B., Subbotina, N., Ling, S., Teitz‐Tennenbaum, S., Osterholzer, J. J., Sisson, T. H., & Kim, K. K. (2024) · Figshare · doi:10.6084/m9.figshare.24820076
Morozan, A. (2023) · eScholarship@McGill (McGill) · doi:10.82308/54309
Ephrin-B2 and EphB4 Signaling in the Development of Fibrosis
Wu, B. (2023) · TSpace (University of Toronto)
Circulating miR-378a-3p attenuates pulmonary inflammation and fibrosis via BAT-lung crosstalk
He, R., Peng, X., Pan, R., Kang, Q., Liu, S., Yang, M., Wang, Z., Deng, H., Li, D., Xie, Y., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04296-3
“[6] Although the nintedanib and pirfenidone have been approved for the treatment of PF, [7] they fail to stop the disease progression of PF, [8, 9] underscoring the need for new targets and modalities.”
シリカ誘導肺線維症モデルマウスを用いた間質マクロファージの病態生理学的役割の解明
Tatsuro, O. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.20604/00003723
Rôle des FGFs endocrines et leurs récepteurs au cours de la fibrose pulmonaire idiopathique
Ghanem, M. (2023) · theses.fr (ABES) · doi:10.70675/fd0d64f8zacf4z4856z9b1az66d4df37a332
Profibrotic macrophage populations and cell communications in pulmonary fibrosis
Zhang, D., Zhao, W., Xu, C., Du, L., & Liu, Q. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01179-x
Wu, P., Jia, J., Jin, T., Luo, B., Zhang, Z., & Wang, G. (2026) · In Vivo · doi:10.21873/invivo.14302
Smyth, T., Brocke, S. A., Wu, W., An, Z., & Jaspers, I. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag050
“When coupled with growing evidence suggesting MDMs contribute to fibrotic responses following inflammation (Misharin et al. 2017; McCubbrey et al. 2018), the need to consider toxicant-induced modifications of MDM populations represents an important area of research.”
Metadata
- Authors
- McCubbrey, A. L., Barthel, L., Mohning, M. P., Redente, E. F., Mould, K. J., Thomas, S. M., Leach, S. M., Danhorn, T., Gibbings, S. L., Jakubzick, C. V., Henson, P. M., & Janssen, W. J.
- Affiliations
- University of Colorado Anschutz (US)
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and
- National Jewish Health (US)
- Corresponding author
- McCubbrey, Alexandra L.
- ORCID
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-01
- Volume
- 58
- Issue
- 1
- Pages
- 66-78
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC5941310
- OpenAlex
- W2750997091
- Cited by
- 195
- References
- 52
- Citations by year
- 2026: 19 · 2025: 30 · 2024: 26 · 2023: 25 · 2022: 24 · 2021: 15 · 2020: 27 · 2019: 15 · 2018: 10
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (IK2 BX002401)
- National Institutes of Health (T32 HL0070-85, NIH T32, P 30CA046934)
- National Heart, Lung, and Blood Institute (R35HL140039, F32HL131397, F32HL126333, R01HL109517, R01HL114381, R01HL130938, T32HL007085)
- National Cancer Institute (P30CA046934)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- c-FLIP, idiopathic pulmonary fibrosis, bleomycin-induced lung fibrosis, macrophage apoptosis, monocyte-derived macrophages, alveolar macrophages, Siglec-F, chemokines, growth factors, macrophage depletion
- MeSH terms
- Animals, Bleomycin, Female, Humans, Macrophages, Male, Pulmonary Fibrosis, Gene Deletion, CD11 Antigens, Mice, CASP8 and FADD-Like Apoptosis Regulating Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.